Bioactive Products
| A unique collection of 35 Antileukaemic natural compound library for Antileukaemic screening | ||
| Catalog No: | B29 | Antileukaemic Compound Library Screening Details |
| Size: | 1mg/well * 35 Compounds 2mg/well * 35 Compounds | |
| Cat. No. | Information |
| CFN90091 | 1-Indanone 1-Indanone thiosemicarbazones coordinated to palladium(II) is more cytotoxic than those complexed with platinum(II); although platinum(II) is more selective for leukemic cells and has potential to treat hematological malignancies. |
| CFN98589 | Vincristine Vincristine-induced nociceptive painful sensation, may be due to its potential of antioxidative, neuroprotective and calcium channel inhibitory action.Vincristine can treat MM, ERK1/2, Akt, and NF-κB inhibitors are potentially useful as anti-MDR agents for the treatment of Vincristine-resistant MM. An inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of Vincristine-related peripheral neuropathy. |
| CFN98852 | Lochnerine Lochnerine shows potent vasorelaxant activity, it also shows some antitumor activity, it can bring about complete inhibition of cell growth in P388 leukemia cells in vitro. |
| CFN98861 | Quercetin 3-O-robinobioside Quercetin-3-O-robinobioside is a quercetin-derived flavonol, exhibits antioxidant activities. It exhibits in-vitro inhibitory activities against leukemia K562 cells. |
| CFN98872 | Magnolol Magnolol is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively. Magnolol has antifungal, antibacterial, anti-oxidative, antidepressant-like, anti- tumor, and neuroprotective effects, it also prevents skin photoaging in UVB-irradiated hairless mice. Magnolol has a wide spectrum of targets including TNF-α, NF-KB, GSK3β. |
